Management of 13 cases of canine respiratory disease using inhaled corticosteroids.
OBJECTIVES: To determine the value of inhaled corticosteroids in the management of chronic inflammatory airway disease in dogs. METHODS: Medical records of dogs that were presented for the investigation of respiratory disease were reviewed retrospectively. Criteria for inclusion were knowledge of pr...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1797066109717839872 |
|---|---|
| author | Bexfield, N Foale, R Davison, L Watson, P Skelly, B Herrtage, M |
| author_facet | Bexfield, N Foale, R Davison, L Watson, P Skelly, B Herrtage, M |
| author_sort | Bexfield, N |
| collection | OXFORD |
| description | OBJECTIVES: To determine the value of inhaled corticosteroids in the management of chronic inflammatory airway disease in dogs. METHODS: Medical records of dogs that were presented for the investigation of respiratory disease were reviewed retrospectively. Criteria for inclusion were knowledge of previous medical treatment including side effects, diagnosis of the underlying disease, use of inhaled corticosteroids and at least two-months follow-up data. RESULTS: Thirteen dogs that fulfilled the criteria were identified. Ten dogs were diagnosed with chronic bronchitis and three with eosinophilic bronchopneumopathy. Four dogs had not previously received corticosteroid treatment for their respiratory disease, and all these showed a reduction or a resolution of clinical signs without obvious side effects after inhaled corticosteroid therapy. Nine dogs had previously received oral or parenteral corticosteroids for treatment of their respiratory disease, and all had exhibited side effects. Five of these dogs were treated with inhaled corticosteroids alone, and all exhibited an improvement in clinical signs without observable side effects. The remaining four dogs were treated with a combination of inhaled and oral corticosteroids, and all showed improvement in clinical signs and reduction in side effects. Inhaled medication was well tolerated in all dogs. CLINICAL SIGNIFICANCE: Inhaled corticosteroids were used for the management of chronic bronchitis and eosinophilic bronchopneumopathy in 13 dogs, and these may have the advantage of reducing side effects associated with oral corticosteroids. |
| first_indexed | 2024-03-06T21:37:41Z |
| format | Journal article |
| id | oxford-uuid:46d47ba6-1708-494c-9cdd-7fc31f57a64b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:37:41Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:46d47ba6-1708-494c-9cdd-7fc31f57a64b2022-03-26T15:16:12ZManagement of 13 cases of canine respiratory disease using inhaled corticosteroids.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:46d47ba6-1708-494c-9cdd-7fc31f57a64bEnglishSymplectic Elements at Oxford2006Bexfield, NFoale, RDavison, LWatson, PSkelly, BHerrtage, MOBJECTIVES: To determine the value of inhaled corticosteroids in the management of chronic inflammatory airway disease in dogs. METHODS: Medical records of dogs that were presented for the investigation of respiratory disease were reviewed retrospectively. Criteria for inclusion were knowledge of previous medical treatment including side effects, diagnosis of the underlying disease, use of inhaled corticosteroids and at least two-months follow-up data. RESULTS: Thirteen dogs that fulfilled the criteria were identified. Ten dogs were diagnosed with chronic bronchitis and three with eosinophilic bronchopneumopathy. Four dogs had not previously received corticosteroid treatment for their respiratory disease, and all these showed a reduction or a resolution of clinical signs without obvious side effects after inhaled corticosteroid therapy. Nine dogs had previously received oral or parenteral corticosteroids for treatment of their respiratory disease, and all had exhibited side effects. Five of these dogs were treated with inhaled corticosteroids alone, and all exhibited an improvement in clinical signs without observable side effects. The remaining four dogs were treated with a combination of inhaled and oral corticosteroids, and all showed improvement in clinical signs and reduction in side effects. Inhaled medication was well tolerated in all dogs. CLINICAL SIGNIFICANCE: Inhaled corticosteroids were used for the management of chronic bronchitis and eosinophilic bronchopneumopathy in 13 dogs, and these may have the advantage of reducing side effects associated with oral corticosteroids. |
| spellingShingle | Bexfield, N Foale, R Davison, L Watson, P Skelly, B Herrtage, M Management of 13 cases of canine respiratory disease using inhaled corticosteroids. |
| title | Management of 13 cases of canine respiratory disease using inhaled corticosteroids. |
| title_full | Management of 13 cases of canine respiratory disease using inhaled corticosteroids. |
| title_fullStr | Management of 13 cases of canine respiratory disease using inhaled corticosteroids. |
| title_full_unstemmed | Management of 13 cases of canine respiratory disease using inhaled corticosteroids. |
| title_short | Management of 13 cases of canine respiratory disease using inhaled corticosteroids. |
| title_sort | management of 13 cases of canine respiratory disease using inhaled corticosteroids |
| work_keys_str_mv | AT bexfieldn managementof13casesofcaninerespiratorydiseaseusinginhaledcorticosteroids AT foaler managementof13casesofcaninerespiratorydiseaseusinginhaledcorticosteroids AT davisonl managementof13casesofcaninerespiratorydiseaseusinginhaledcorticosteroids AT watsonp managementof13casesofcaninerespiratorydiseaseusinginhaledcorticosteroids AT skellyb managementof13casesofcaninerespiratorydiseaseusinginhaledcorticosteroids AT herrtagem managementof13casesofcaninerespiratorydiseaseusinginhaledcorticosteroids |